Conference Coverage

AVAHO 2014 Meeting: Lymphoma Mini-Symposium Preview

Dr. Adrian Weistner and Dr. Mark Roschewski discuss what to expect during their presentations and panel discussion.

Publish date: September 9, 2014

 

Federal Practitioner recently talked with Dr. Adrian Weistner and Dr. Mark Roschewski of the National Institutes of Health. Both doctors will be presenting during the September 12, 2014 Lymphoma Mini-Symposium and panel discussion that kicks off this weekend’s 2014 AVAHO Meeting in Portland, Oregon.

Recommended Reading

Neutropenia and the White Blood Cells
AVAHO
Protecting Patients with HCV from Lymphoma
AVAHO
Burkitt Lymphoma Presenting as Thoracic Back Pain
AVAHO
Psoriasis: The Lymphoma Link
AVAHO
Thyroid Lymphoma
AVAHO
The Role of Autologous Hematopoietic Stem Cell Transplantation in Mantle Cell Lymphoma
AVAHO
Treatment Failure Patterns in Patients With Chronic Lymphocytic Leukemia: Results of a Large U.S. Observational Study
AVAHO
Association Between Rituximab Use and Progressive Multifocal Leukoencephalopathy Among Non-HIV Non-Hodgkin Lymphoma VA Patients
AVAHO
Case Report of Dasatinib-Induced Follicular Lymphoid Hyperplasia
AVAHO

Related Articles

  • Clinical Topics & News

    Blast Phase Chronic Myelogenous Leukemia

    Author:
    Benjamin Powers, MD
    Suman Kambhampati, MD

    The dramatic improvement in survival with tyrosine kinase inhibitors has not been demonstrated in the advanced blast phase of chronic myelogenous...